ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,949,134 | +1.9% | 10,133 | -2.5% | 0.06% | -3.3% |
| Q1 2023 | $3,874,087 | -1.6% | 10,398 | 0.0% | 0.06% | -7.6% |
| Q4 2022 | $3,939,074 | +6.8% | 10,398 | -0.5% | 0.07% | +3.1% |
| Q3 2022 | $3,689,000 | -8.3% | 10,448 | -1.6% | 0.06% | -1.5% |
| Q2 2022 | $4,025,000 | +17.9% | 10,623 | -1.9% | 0.06% | +35.4% |
| Q1 2022 | $3,414,000 | -47.3% | 10,828 | -41.5% | 0.05% | -40.7% |
| Q4 2021 | $6,479,000 | +14.4% | 18,500 | -1.3% | 0.08% | +2.5% |
| Q3 2021 | $5,661,000 | +1.5% | 18,745 | +1.2% | 0.08% | +1.3% |
| Q2 2021 | $5,578,000 | +14.3% | 18,528 | +4.5% | 0.08% | +2.6% |
| Q1 2021 | $4,881,000 | -13.9% | 17,725 | -8.0% | 0.08% | -17.4% |
| Q4 2020 | $5,666,000 | +8.2% | 19,267 | -3.4% | 0.09% | -5.2% |
| Q3 2020 | $5,235,000 | +639.4% | 19,940 | +534.0% | 0.10% | +592.9% |
| Q2 2020 | $708,000 | – | 3,145 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
| Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
| Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
| Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
| Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
| AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
| DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
| Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
| JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
| Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |